Scarica l'app Stockscreener
34.03
2.72%
-0.95
Dopo l'orario di chiusura:
34.69
0.66
+1.94%
Dianthus Therapeutics Inc Azioni (DNTH) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
83.40%
0.193
|
1.163 | 1.326 | 2.172 | 1.863 |
Operating Expenses
|
2.27%
35.12
|
34.34 | 33.24 | 32.07 | 24.07 |
| Benefits Costs and Expenses |
100.00%
-
|
30.67 | 29.77 | 27.35 | 19.47 |
| Costs And Expenses |
14.49%
35.12
|
30.67 | 16.35 | 32.07 | 24.07 |
| Operating Income/Loss |
5.27%
-34.93
|
-33.18 | -31.92 | -29.90 | -22.20 |
| Nonoperating Income/Loss |
10.04%
3.298
|
3.666 | 3.476 | 4.726 | 4.597 |
| Income/Loss From Continuing Operations Before Tax |
100.65%
0.193
|
-29.51 | -28.44 | -25.17 | -17.61 |
| Income/Loss From Continuing Operations After Tax |
7.18%
-31.63
|
-29.51 | -28.44 | -25.17 | -17.61 |
|
Net Income/Loss
|
7.18%
-31.63
|
-29.51 | -28.44 | -25.17 | -17.61 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.09%
35.82
|
35.79 | 0.6991 | 34.24 | 34.23 |
| Diluted Average Shares |
0.09%
35.82
|
35.79 | 0.6991 | 34.24 | 34.23 |
| Basic Earnings Per Share |
7.32%
-0.88
|
-0.82 | -0.82 | -0.74 | -0.51 |
| Diluted Earnings Per Share |
7.32%
-0.88
|
-0.82 | -0.82 | -0.74 | -0.51 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.64%
0.35%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):